- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 323/32 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
Patent holdings for IPC class C07C 323/32
Total number of patents in this class: 81
10-year publication summary
6
|
3
|
6
|
7
|
5
|
3
|
2
|
7
|
6
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Acucela Inc. | 159 |
7 |
Enzo Therapeutics, Inc. | 31 |
7 |
Mitsubishi Tanabe Pharma Corporation | 580 |
5 |
Virginia Commonwealth University | 617 |
5 |
vTv Therapeutics LLC | 154 |
4 |
Cybin IRL Limited | 51 |
4 |
KYORIN Pharmaceutical Co., Ltd. | 172 |
3 |
Sunovion Pharmaceuticals Inc. | 290 |
3 |
Gilgamesh Pharmaceuticals, Inc. | 48 |
3 |
Roche Diagnostics Operations, Inc. | 1446 |
2 |
3m Innovative Properties Company | 18002 |
2 |
Centre National de La Recherche Scientifique | 10163 |
2 |
Adeka Corporation | 1350 |
2 |
DNP Fine Chemicals Co., Ltd. | 174 |
2 |
Nabriva Therapeutics AG | 23 |
2 |
Reviva Pharmaceuticals, Inc. | 45 |
2 |
Priothera Limited | 10 |
2 |
Bristol-myers Squibb Company | 4879 |
1 |
Pfizer Inc. | 3375 |
1 |
Allergan, Inc. | 2429 |
1 |
Other owners | 21 |